The Role of Systemic Immunomodulatory Treatment and Prognostic Factors on Chronic Ocular Complications in Stevens–Johnson Syndrome

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

Sylvie Bastuji‐Garin · Archives of Dermatology · 1993 · 1.6K citations

SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

Nathalie Fouchard, M. Bertocchi, Jean‐Claude Roujeau et al. · Journal of Investigative Dermatology · 2000 · 1.2K citations · Full text

Toxic Epidermal Necrolysis, Clinical Dermatology, Wound Healing +4

Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

I. Viard, Philippe Wehrli, Roberto Bullani et al. · Science · 1998 · 1K citations

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

Maja Mockenhaupt, Cécile Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology · 2007 · 978 citations · Full text

Drug Safety, Toxic Epidermal Necrolysis, Recently Marketed Drugs +10

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin

Transfusion Medicine Reviews · 1999 · 871 citations

Clinical Immunology, Toxic Epidermal Necrolysis, Autoimmune Disease +11